Atlas Trials

CY-503 for the Treatment of Chemotherapy-refractory Metastatic Colorectal Cancer

Clinical trial NCT00932724 · TERMINATED

Trial details

NCT number
NCT00932724
Sponsor
Cytavis Biopharma GmbH
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2009-07-01
Primary completion
2012-08-01
Enrollment
77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.